These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 31850625)

  • 21. A chemically modified nonantimicrobial tetracycline (CMT-8) inhibits gingival matrix metalloproteinases, periodontal breakdown, and extra-oral bone loss in ovariectomized rats.
    Golub LM; Ramamurthy NS; Llavaneras A; Ryan ME; Lee HM; Liu Y; Bain S; Sorsa T
    Ann N Y Acad Sci; 1999 Jun; 878():290-310. PubMed ID: 10415737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemically modified tetracyclines: The novel host modulating agents.
    Swamy DN; Sanivarapu S; Moogla S; Kapalavai V
    J Indian Soc Periodontol; 2015; 19(4):370-4. PubMed ID: 26392682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: a mechanistic link between local and systemic inflammation.
    Gu Y; Lee HM; Sorsa T; Salminen A; Ryan ME; Slepian MJ; Golub LM
    Pharmacol Res; 2011 Dec; 64(6):573-9. PubMed ID: 21771657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemically modified tetracyclines: Novel therapeutic agents in the management of chronic periodontitis.
    Agnihotri R; Gaur S
    Indian J Pharmacol; 2012 Mar; 44(2):161-7. PubMed ID: 22529468
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis.
    Ryan ME; Greenwald RA; Golub LM
    Curr Opin Rheumatol; 1996 May; 8(3):238-47. PubMed ID: 8796985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of the host response in the treatment of periodontitis.
    Golub LM; Ryan ME; Williams RC
    Dent Today; 1998 Oct; 17(10):102-6, 108-9. PubMed ID: 10752438
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemically modified tetracyclines an emerging host modulator in chronic periodontitis patients: A randomized, double-blind, placebo-controlled, clinical trial.
    Alyousef AA; Divakar DD; Muzaheed
    Microb Pathog; 2017 Sep; 110():279-284. PubMed ID: 28687322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms.
    Golub LM; Lee HM; Ryan ME; Giannobile WV; Payne J; Sorsa T
    Adv Dent Res; 1998 Nov; 12(2):12-26. PubMed ID: 9972117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.
    Wang HH; Lee HM; Raja V; Hou W; Iacono VJ; Scaduto J; Johnson F; Golub LM; Gu Y
    J Exp Pharmacol; 2019; 11():1-14. PubMed ID: 30774454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and laminin-5 gamma2 chain immunolocalization in gingival tissue of endotoxin-induced periodontitis in rats: effects of low-dose doxycycline and alendronate.
    Buduneli E; Vardar-Sengül S; Buduneli N; Atilla G; Wahlgren J; Sorsa T
    J Periodontol; 2007 Jan; 78(1):127-34. PubMed ID: 17199549
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Introduction and background.
    Golub LM
    Pharmacol Res; 2011 Feb; 63(2):99-101. PubMed ID: 20937387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs.
    Golub LM; Ramamurthy NS; McNamara TF; Greenwald RA; Rifkin BR
    Crit Rev Oral Biol Med; 1991; 2(3):297-321. PubMed ID: 1654139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease.
    Ramamurthy NS; Xu JW; Bird J; Baxter A; Bhogal R; Wills R; Watson B; Owen D; Wolff M; Greenwald RA
    J Periodontal Res; 2002 Feb; 37(1):1-7. PubMed ID: 11842933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetracyclines inhibit Porphyromonas gingivalis-induced alveolar bone loss in rats by a non-antimicrobial mechanism.
    Chang KM; Ramamurthy NS; McNamara TF; Evans RT; Klausen B; Murray PA; Golub LM
    J Periodontal Res; 1994 Jul; 29(4):242-9. PubMed ID: 7932017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetracyclines in the management of periodontal diseases. A review.
    Seymour RA; Heasman PA
    J Clin Periodontol; 1995 Jan; 22(1):22-35. PubMed ID: 7706536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levels and molecular forms of MMP-7 (matrilysin-1) and MMP-8 (collagenase-2) in diseased human peri-implant sulcular fluid.
    Kivelä-Rajamäki M; Maisi P; Srinivas R; Tervahartiala T; Teronen O; Husa V; Salo T; Sorsa T
    J Periodontal Res; 2003 Dec; 38(6):583-90. PubMed ID: 14632921
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacologic management of periodontal diseases using systemically administered agents.
    Mariotti A; Monroe PJ
    Dent Clin North Am; 1998 Apr; 42(2):245-62. PubMed ID: 9597336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host modulation therapeutics in periodontics: role as an adjunctive periodontal therapy.
    Shinwari MS; Tanwir F; Hyder PR; Bin Saeed MH
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):676-84. PubMed ID: 25233975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenic women.
    Golub LM; Lee HM; Stoner JA; Sorsa T; Reinhardt RA; Wolff MS; Ryan ME; Nummikoski PV; Payne JB
    J Periodontol; 2008 Aug; 79(8):1409-18. PubMed ID: 18672990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenesis of periodontitis: role of cytokines in host response.
    Deo V; Bhongade ML
    Dent Today; 2010 Sep; 29(9):60-2, 64-6; quiz 68-9. PubMed ID: 20973418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.